SentiSense
Ctrl+K
Quick tip: Press
to search stocks
B
BSX
Boston Scientific Corporation
$71.35
-1.64 (-2.25%)
Summary
Stories
News
Metrics
Fundamentals
Recent News
Filter:
Showing 10 of 10 articles
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
GlobeNewswire Inc.
•
7 hours ago
•
Negative
BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
GlobeNewswire Inc.
•
1 day ago
•
Negative
Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? - Yahoo! Finance Canada
Unknown
•
1 day ago
•
Negative
Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? - Yahoo Finance
Unknown
•
1 day ago
•
Negative
IYH, BMY, MDT, BSX: Large Outflows Detected at ETF - Nasdaq
Unknown
•
1 day ago
•
Neutral
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Boston Scientific Corporation Common Stock and Sets a Lead Plaintiff Deadline of May 4, 2026
GlobeNewswire Inc.
•
2 days ago
•
Negative
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages
The Motley Fool
•
2 days ago
•
Positive
TD Cowen reiterates Boston Scientific stock rating on guidance confidence
Investing.com
•
3 days ago
•
Neutral
Boston Scientific Corporation Investigated by the Portnoy Law Firm
GlobeNewswire Inc.
•
3 days ago
•
Negative
The Zacks Analyst Blog Highlights Apple, TotalEnergies, Boston Scientific and Good Times Restaurants - Yahoo Finance
Unknown
•
4 days ago
•
Neutral
Company Profile
Symbol
BSX
Market Cap
$105.88B
IPO Date
May 18, 1992
CEO
--
Employees
59,000
Sector
--
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Country
United States
Exchange
--
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Read MoreSimilar Stocks
MDT
Medtronic plc
$90.90
-2.27%
ABT
Abbott Laboratories
$109.56
-1.33%
MDT
Medtronic plc
$90.90
-2.27%
ISRG
Intuitive Surgical, Inc.
$490.16
-1.32%